arrow
P

Patricia Baxter

Texas Children's Cancer Center
H指数:27
被引数:2,641

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TIP-30. Molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG): CONNECT TarGeT (Targeted pediatric HGG therapy) trial in progress

TIP-30. 分子引导的针对新诊断的高级别胶质瘤(HGG,包括弥漫性内生性脑桥胶质瘤(DIPG)的儿童及青少年患者的二期伞式临床试验:正在进行的CONNECT TarGeT(靶向儿科HGG疗法)试验。

2025-11-110
OA
MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
2024-11-110
PRE
A PHASE 1/2 STUDY ASSESSING SAFETY AND PHARMACOKINETICS OF CEMIPLIMAB IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID OR CENTRAL-NERVOUS-SYSTEM TUMORS AND SAFETY AND EFFICACY OF CEMIPLIMAB IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA, NEWLY DIAGNOSED HIGH-GRADE GLIOMA, OR RECURRENT HIGH-GRADE GLIOMA
2024-06-180
OAAI
PSYCHOSOCIAL OUTCOMES OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG) -PROSPECTIVE, LONGITUDINAL PROMIS ASSESSMENTS OF PATIENTS ENROLLED ON CONNECT PHASE I CLINICAL TRIALS
2024-06-180
OAAI
Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models
2023-07-064
OAAI
UPDATED FINDINGS FROM THE PHASE IB STUDY OF UNESBULIN (PTC596) IN CHILDREN WITH NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)

新诊断的弥漫性内在性脑桥胶质瘤 (DIPG) 和高级别胶质瘤 (HGG) 儿童UNESBULIN (PTC596) IB期研究的最新发现: 来自神经肿瘤学临床试验合作网络 (CONNECT) 的报告

2023-06-120
OAAI
A First Look at Equity, Diversity, and Inclusion of Canadian Medical Physicists: Results From the 2021 COMP EDI Climate Survey

加拿大医学物理学家的公平性、多样性和包容性: 2021 COMP EDI气候调查的结果

2023-06-016
PRE
Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas (vol 13, 6689, 2022)
2022-12-220
OAAI
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
2022-06-0213
OA
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report

瑞博西尼和依维莫司在新诊断的DIPG和高级别神经胶质瘤患儿中的I期研究: 小儿神经肿瘤学联合会的报告

2022-04-168
OAAI
LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study (vol 20, pg i214, 2018)
2022-03-210
OA
Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion
2021-11-0112
OA
Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma

接受被动散射质子或光子颅脊髓照射治疗髓母细胞瘤的儿童患者的总生存期及继发性恶性肿瘤发生情况

CANCER
IF5.1
2021-07-1321
OAAI
Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors (vol 493, pg 197, 2020)
2021-03-010
OAAI